Skip to search formSkip to main content

13,14-dehydroprostaglandin I2 methyl ester

Known as: 13,14-dehydroprostacyclin methyl ester, 13,14-dehydro PGI2 methyl ester, prost-5-en-13-yn-1-oic acid, 6,9-epoxy-11,15-dihydroxy-, methyl ester, (5Z,9 alpha,11 alpha,15S)- 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
This study aimed to determine whether prostacyclin (PGI2) functions as an endothelium-derived contracting factor (EDCF) in young… Expand
  • table 1
Is this relevant?
1984
1984
The main aims of the research for new PGI2 analogues are to increase (1) the duration of action and/or (2) biological selectivity… Expand
Is this relevant?
1983
1983
Fluoroprostacyclin (10,10-difluoro-13,14-dehydroprostacyclin) a stable analogue of PGI2, induced an increase of contractile… Expand
Is this relevant?
1982
1982
Elevation of cyclic adenosine 3',5'-monophosphate (cyclic AMP) in elicited populations of rat peritoneal macrophages was used as… Expand
Is this relevant?
1978
1978
The effects of a recently synthesized, stable prostacyclin (PGI2) analog, 13,14-dehydro-PGI2 methyl ester, and authentic PGI2 and… Expand
Is this relevant?
1977
1977
Microsomes from stomach fundus and blood vessels transform the endoperoxide, PGH2, into a newly discovered unstable substance… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?